Michael C Mulica insider trades: DNA X (SONM) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Michael reports to the SEC
Open-market buys and sales
4 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Apr 23, 2025 | SONM | ↓ Sell | 27,818 | $1.45 | $40K | Direct | Apr 25, 2025 (2d) |
| Nov 13, 2024 | SONM | ↓ Sell | 2,559 | $3.28 | $8K | Direct | Nov 14, 2024 (1d) |
| Jun 21, 2024 | SONM | ↓ Sell | 36,016 | $0.69 | $25K | Direct | Jun 24, 2024 (3d) |
| Mar 24, 2014 | UPIP | ↑ Buy | 100,000 | $2.00 | $200K | Direct | Mar 26, 2014 (2d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Michael C Mulica's insider trades
Michael C Mulica is Acting CEO at DNA X (SONM). Since Mar 24, 2014, Michael has reported 1 open-market purchase worth $200K and 3 sales worth $74K on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (21 filings), option exercises (2 filings), shares withheld for taxes (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SONM insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.